human plasma coagulation factor viii
ItalyDrugs containing this active substance
-
It is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency).
Form: solution for injection, powder and solvent
Active substance Dosage human plasma coagulation factor viii - ATC: B02BD02
Manufacturer: BIOTEST PHARMA GMBH
-
KLOTT is used for the treatment and prevention of bleeding in patients with hemophilia A (an inherited deficiency of factor VIII) or in patients presenting with a deficiency of this factor due to other diseases. It is also indicated for hemophilic patients who have developed antibodies against factor VIII (inhibitors).
Form: solution for infusion, powder and solvent for preparation
Active substance Dosage human plasma coagulation factor viii - ATC: B02BD02
Manufacturer: KEDRION S.P.A.